Better Healthcare ETF: Fidelity's Broad, Low-Cost FHLC vs. State Street's XBI Targeting Biotech

The article says the Fidelity MSCI Health Care Index ETF has a significantly lower expense ratio and a more diversified portfolio than the State Street SPDR S&P Biotech ETF. It provides no specific fee, diversification, or performance figures.